Use of relative effectiveness information in reimbursement and pricing decisions in Europe

Author： van Nooten Floortje   Caro J Jaime  

Publisher： Future Medicine

ISSN： 2042-6305

Source： Journal of Comparative Effectiveness Research, Vol.2, Iss.1, 2013-01, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pricing and reimbursement of drugs in Ireland

By Barry Michael   Tilson Lesley   Ryan Máirín  

The European Journal of Health Economics, Vol. 5, Iss. 2, 2004-05 ,pp. : 190-194

Springer Publishing Company

Access to resources Recommend Favorite

Pricing and reimbursement of pharmaceuticals in Italy

By Folino-Gallo Pietro  

The European Journal of Health Economics, Vol. 9, Iss. 3, 2008-08 ,pp. : 305-310

Springer Publishing Company

Access to resources Recommend Favorite

Orphan drugs: pricing, reimbursement and patient access

By Barak Adam   Nandi Jyoti Shankar  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5, Iss. 4, 2011-11 ,pp. : 299-317

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIA

By  

International Journal of Technology Assessment in Health Care, Vol. 33, Iss. 3, 2017-08 ,pp. : 365-370

Cambridge University Press

Access to resources Recommend Favorite

Interview: European collaboration in relative effectiveness assessment: the use of patient registries and development of common guidelines

By Goettsch Wim  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 4, 2013-07 ,pp. : 371-373

Future Medicine

Access to resources Recommend Favorite